119879-92-4 Usage
Uses
Used in Pharmaceutical Research:
N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester is used as a potential drug candidate for the treatment of various diseases due to its demonstrated anti-inflammatory and anti-tumor effects in preclinical studies.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester is utilized for the synthesis and characterization of novel therapeutic agents. Its unique chemical structure and pharmacological properties make it an important compound for further research and development.
Used in Drug Development:
N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester is employed in drug development as a starting material or intermediate for the synthesis of new pharmaceutical compounds with potential therapeutic applications.
Used in Preclinical Studies:
In preclinical studies, N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester is used to evaluate its pharmacological activity, including its anti-inflammatory and anti-tumor effects, to determine its potential as a therapeutic agent for various diseases.
Used in Chemical Synthesis:
N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester is used as a key intermediate in the chemical synthesis of related compounds with potential applications in the pharmaceutical industry.
Used in Drug Discovery:
In drug discovery, N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester serves as a valuable compound for screening and optimization to identify new drug candidates with improved therapeutic properties.
Used in Chemical Libraries:
N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester is incorporated into chemical libraries for high-throughput screening to identify potential lead compounds for drug development.
Used in Structure-Activity Relationship Studies:
In structure-activity relationship studies, N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester is used to investigate the relationship between its chemical structure and its pharmacological activity, providing insights for the design of more effective therapeutic agents.
Used in Medicinal Chemistry Education:
N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester serves as a case study in medicinal chemistry education, illustrating the principles of drug design, synthesis, and evaluation of pharmacological activity.
Check Digit Verification of cas no
The CAS Registry Mumber 119879-92-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,8,7 and 9 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 119879-92:
(8*1)+(7*1)+(6*9)+(5*8)+(4*7)+(3*9)+(2*9)+(1*2)=184
184 % 10 = 4
So 119879-92-4 is a valid CAS Registry Number.
119879-92-4Relevant academic research and scientific papers
BUILDING BLOCKS FOR DNA BINDING AGENTS
-
Page/Page column 29, (2008/06/13)
The invention provides an alkylator that is an analog of a compound based on 5-oxo-1a,2,3,5-tetrahydro-1H-3-aza-cyclopropa[c]indene-7-carboxylic acid, 9a-chloromethyl-4-oxo-2,4,9,9a-tetrahydro-1H-2-aza-cyclopropa[1,5]cyclopenta[1,2-a]naphthalene-7-carboxylic acid, or 4-oxo-1,2,4,5,8,8a-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-6-carboxylic acid and conjugates thereof.
Synthesis of N-(phenylsulfonyl)-CI, N-((tert-butyloxy)carbonyl)-CI, CI-CDPI 1, and CI-CDPI 2: CC-1065 functional analogues incorporating the parent 1,2,7,7a-tetrahydrocycloprop[1,2-c]indol-4-one (CI) left-hand subunit
Boger, Dale L.,Wysocki Jr., Ronald J.,Ishizaki, Takayoshi
, p. 5230 - 5240 (2007/10/02)
Full details of the synthesis of N-(phenylsulfonyl)- and N-((tert-butyloxy)carbonyl)-1,2,7,7a-tetrahydrocycloprop[1,2-c]indol-4-one [N-(phenylsulfonyl)-CI (9) and N-BOC-CI (10)] constituting stable derivatives of the parent cyclopropylcyclohexadienone rin
